Scientists provided novel androgen receptor (AR)-directed proteolysis-targeting chimeras (PROTACs) and a clear rationale for further investigating AR involvement in lung cancer models.
[Archiv Der Pharmazie]
7992332
{7992332:AAAAAAAA}
apa
50
1
171746
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/